Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses

Abstract

BackgroundThe outbreak of Coronavirus disease 2019 (COVID-19) has become an international public health crisis, and the number of cases with dengue co-infection has raised concerns. Unfortunately, treatment options are currently limited or even unavailable. Thus, the aim of our study was to explore the underlying mechanisms and identify potential therapeutic targets for co-infection.MethodsTo further understand the mechanisms underlying co-infection, we used a series of bioinformatics analyses to build host factor interaction networks and elucidate biological process and molecular function categories, pathway activity, tissue-specific enrichment, and potential therapeutic agents.ResultsWe explored the pathologic mechanisms of COVID-19 and dengue co-infection, including predisposing genes, significant pathways, biological functions, and possible drugs for intervention. In total, 460 shared host factors were collected; among them, CCL4 and AhR targets were important. To further analyze biological functions, we created a protein-protein interaction (PPI) network and performed Molecular Complex Detection (MCODE) analysis. In addition, common signaling pathways were acquired, and the toll-like receptor and NOD-like receptor signaling pathways exerted a significant effect on the interaction. Upregulated genes were identified based on the activity score of dysregulated genes, such as IL-1, Hippo, and TNF-α. We also conducted tissue-specific enrichment analysis and found ICAM-1 and CCL2 to be highly expressed in the lung. Finally, candidate drugs were screened, including resveratrol, genistein, and dexamethasone.ConclusionsThis study probes host factor interaction networks for COVID-19 and dengue and provides potential drugs for clinical practice. Although the findings need to be verified, they contribute to the treatment of co-infection and the management of respiratory disease.

‘Dengue-COVID-19 overlap’: Is it an ‘antigenic mimicry’ or coexistent two different viral genotypic diseases? Prospective, observational study in tertiary care setting in India

“…Initially, dengue-COVID-19 overlap was considered important health issue in ongoing COVID-19 pandemic in high dengue burden setting in tropical countries in South East Asia region and as pandemic grown across globe irrespective of dengue trends, now it is considered as global health issue. Various studies [41,42] and the studies [13,40] documented similar observation.…”

Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals

“…These complexes were observed essentially during the acute phase of active tuberculosis or acute dengue fever infection ( 20 ). Acute tuberculosis and dengue fever present similarities with SARS-CoV-2-associated symptoms ( 21 , 22 ) and the three pathogens were also able to increase peripheral cytokines’ levels such as IFN-γ and thus, dysregulate the innate and adaptive immune system ( 23 , 24 ). Even though we have not determined if the CD14+ CD3+ subset observed in our study is related to those complexes, there are associated with former COVID-19 individuals who presented immune system inflammation and dysregulation.…”

Identification of stage-related and severity-related biomarkers and exploration of immune landscape for Dengue by comprehensive analyses

“…Interestingly, KEGG enrichment showed DEGs (between the EA stage and the C stage, and between the EA stage and the LA stage) were enriched in Coronavirus disease —COVID-19, Influenza A, Hepatitis C and Measles pathways, implying Coronavirus [ 54 ], Alphainfluenzavirus influenzae [ 55 ], Hepatitis C virus [ 56 ] and Measles morbillivirus also up regulated these genes during infection and had shared pathogenic mechanism.…”